IL-6-anti-IL-6 autoantibody complexes with IL-6 activity in sera from some patients with systemic sclerosis

Journal of Immunology

Volumn 152, Issue 2, 1994, Pages 935-942

  Suzuki, Hiroshi ^a   Takemura, Hiroyuki ^a   Yoshizaki, Kazuyuki ^b   Koishihara, Yasuo ^c   Ohsugi, Yoshiyuki ^c   Okano, Akira ^d   Akiyama, Yukio ^d   Tojo, Takeshi ^e   Kishimoto, Tadamitsu ^b   Kashiwagi, Heihachiro ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^c CHUGAI PHARMACEUTICAL CO LTD   (Japan)

^d AJINOMOTO CO INC   (Japan)

^e National Hospital Organization   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE RECEPTOR; INTERLEUKIN 6;

ARTICLE; BINDING SITE; CLINICAL ARTICLE; CONTROLLED STUDY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; SYSTEMIC SCLEROSIS;

ANTIGEN-ANTIBODY COMPLEX; AUTOANTIBODIES; CARRIER PROTEINS; HUMANS; INTERLEUKIN-6; RECEPTORS, INTERLEUKIN; RECEPTORS, INTERLEUKIN-6; RECOMBINANT PROTEINS; SCLERODERMA, SYSTEMIC;

EID: 0028218523     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Sevenson, M., L. K. Poulsen, A. Fomsgaard, and K. Bendtzen. 1989. IgG autoantibodies against interleukin la in sera of normal subjects. Scand. J. Immunol 29:489.
2. Suzuki, H., T. Akama, M. Okane, I. Kono, Y. Matsui, K. Yamane, and H. Kashiwagi. 1989. Interleukin-1-inhibitory IgG in sera from some patients with rheumatoid arthritis. Arthritis Rheum. 32:1528.
3. Saurai, J.-H., J. Schifferli, G. Steiger, J.-M. Dayer, and L. Didierijean. 1991. Anti-interleukin-1 α autoantibodies in humans: characterization, isotype distribution, and receptor-binding inhibition-Higher frequency in Schnitzler's syndrome (urticaria and macroglobulinemia). J. Allergy Clin. Immunol. 88:244.
4. Fomsgaard, A., M. Svenson, and K. Bendtzen. 1989. Auto-antibodies to tumor necrosis factor α in healthy humans and patients with inflammatory diseases and gram-negative bacterial infections. Scand. J. Immunol. 30:219.
5. Caruso, A., C. Bonfanti, D. Colombrita, M. De Francesco, C. De Rango, I. Foresti, F. Gargiulo, R. Gonzales, G. Gribaudo, S. Londolfo, N. Manca, M. Manni, F. Pirali, P. Pollara, G. Ravizzola, G. Scura, L. Terlenghi, E. Viani, and A. Turano. 1990. Natural antibodies to IFN-γ in man and their increase during viral infection. J. Immunol. 144:685.
6. Panem, S., I. J. Check, D. Hanriksen, and J. Vilcek. 1982. Antibodies to α-interferon in a patient with systemic lupus erythematosus. J. Immunol. 129:1.
7. Bost, K. L., B. H. Hahn, M. S. Saag, G. M. Shaw, D. A. Weigent, and J. E. Blalock. 1988. Individuals infected with HIV possess antibodies against IL-2. Immunology 65:611.
8. Peichl, P., M. Ceska, H. Broell, F. Effenberger, and I. J. D. Lindley. 1992. Human neutrophil-activating peptide/interleukin 8 acts as an autoantigen in rheumatoid arthritis. Ann. Rheum. Dis. 51:19.
9. Sylvester, I., T. Yoshimura, M. Stichering, J.-M. Schroder, M. Ceska, P. Peichl, and E. J. Leonard. 1992. Neurotrophil attractant protein-1-immunoglobulin G immune complexes and free anti-NAP-1 antibody in normal human serum, J. Clin. Invest. 90:471.
10. Bendtzen, K., M. Svenson, V. Jonsson, and E. Hippe. 1990. Autoantibodies to cytokines-friends or foe? Immunol. Today 11:167.
11. Takemura, H., H. Suzuki, K. Yoshizaki, A. Ogata, T. Yuhara, T. Akama, K. Yamane, and H. Kashiwagi. 1992. Anti-interleukin-6 autoantibodies in rheumatic diseases. Increased frequency in the sera of patients with systemic sclerosis. Arthritis Rheum. 35:940.
12. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. 1980. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum. 23:581.
13. Tonouchi, N., N. Oouchi, N. Kashima, M. Kawai, K. Nagase, A. Okano, H. Matsui, K. Yamada, T. Hirano, and T. Kishimoto. 1988. High-level expression of human BSF-2/IL-6 cDNA in Escherichia coli using a new type of expression-preparation system. J. Biochem. 104:30.
14. Takatsuki, F., A. Okano, C. Suzuki, R. Chieda, Y. Takahara, T. Hirano, T. Kishimoto, J. Hamuro, and Y. Akiyama. 1988. Human recombinant IL-6/B cell-stimulating factor 2 augments murine antigen-specific antibody responses in vitro and in vivo. J. Immunol. 141:3072.
15. Yasukawa, K., T. Saito, T. Fukunaga, Y. Sekimori, Y. Koishihara, H. Fukui, Y. Ohsugi, T. Matsuda, H. Yawata, T. Hirano, T. Taga, and T. Kishimoto. 1990. Purification and characterization of soluble human IL-6 receptor expressed in CHO cells. J. Biochem. 108:673.
16. Hirata, Y., T. Taga, M. Hibi, N. Nakano, T. Hirano, and T. Kishimoto. 1989. Characterization of IL-6 receptor expression by monoclonal and polyclonal antibodies. J. Immunol. 143:2900.
17. Matsuda, T., T. Hirano, and T. Kishimoto. 1988. Establishment of an interleukin 6(IL-6)/B cell stimulatory factor 2(BSF-2)-dependent cell line and preparation of anti-IL-6 monoclonal antibodies. Eur. J. Immunol. 18:951.
18. Steward, M. W., and R. E. Petty. 1972. The use of ammonium sulphate globulin precipitation for determination of affinity of antiprotein antibodies in mouse serum. Immunology 22:747.
19. Takemura, H., H. Suzuki, K. Yoshizaki, A. Ogata, T. Yuhara, T. Akama, K. Yamane, and H. Kashiwagi. 1991. Regulation of IL-6 activity by anti-IL-6 autoantibodies found in sera from patients with PSS. Proc. Jpn. Soc. Immunol. 21:184.
20. Suzuki, H., J. Kamimura, T. Ayabe, and H. Kashiwagi. 1990. Demonstration of neutralizing autoantibodies against IL-1α in sera from patients with rheumatoid arthritis. J. Immunol. 145:2140.
21. Honda, M., K. Kitamura, Y. Mizutani, M. Oishi, M. Arai, T. Okura, K. Igarashi, K. Yasukawa, T. Hirano, T. Kishimoto, R. Mistuyasu, J.-C. Chermann. and T. Tokunaga. 1990. Quantitative analysis of serum IL-6 and its correlation with increased levels of serum IL-2R in HIV-induced diseases. J. Immunol. 145:4059.
22. Yoshimoto, T., K. Nakanishi, S. Hirose, K. Hiroishi, H. Okamura, Y. Takemoto, A. Kanamaru, T. Hada, T. Tamura, E. Kakishita, and K. Higashino. 1992. High serum IL-6 level reflects susceptible status of the host to endotoxin and IL-I/tumor necrosis factor. J. Immunol. 148:3596.
23. Svenson, M., M. B. Hansen, and K. Bendtzen. 1990. Distribution and characterization of autoantibodies to interleukin 1α in normal human sera. Scand. J. Immunol. 32:695.
24. Castell, J. V., T. Geiger, V. Gross, T. Andus, E. Walter, T. Hirano, T. Kishimoto, and P. Heinrich. 1988. Plasma clearance, organ distribution, and target cells of interleukin-6/hepatocyte-stimulating factor in the rat. Eur. J. Biochem. 177:357.
25. Kampschmidt, R. F., and H. F. Upchurch. 1980. Rate of clearance of circulating leukocytic endogenous mediator in the rat. Proc. Sco. Exp. Biol. Med. 164:537.
26. Mihara, M., Y. Koishihara, H. Fukui, K. Yasukawa, and Y. Ohsugi. 1991. Murine anti-human IL-6 monoclonal antibody prolongs the half-life in circulating blood and thus prolongs the bioactivity of human IL-6 in mice. Immunology 74:55.
27. Heremans, H., C. Dillen, W. Putt, J. Van Damme, and A. Billiau. 1992. Protective effect of anti-interleukin (IL)-6 antibody against endotoxin, associated with paradoxically increased IL-6 levels. Eur. J. Immunol 22:2395.
28. Taga, T., M. Hibi, Y. Hirata, K. Yamasaki, K. Yasukawa, T. Matsuda, T. Hirano, and T. Kishimoto. 1989. Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130. Cell 58:537.
29. Honda, M., S. Yamamoto, M. Cheng, K. Yasukawa, H. Suzuki, T. Saito, Y. Osugi, T. Tokunaga, and T. Kishimoto. 1992. Human soluble IL-6 receptor: its detection and enhanced release by HIV infection. J. Immunol 148:2175.
30. Fernandez-Botran, R. 1991. Soluble cytokine receptors: their role in immunoregulation. FASEB J. 5:2567.